Hydralazine Hydrochloride; Isosorbide Dinitrate Patent Expiration

Hydralazine Hydrochloride; Isosorbide Dinitrate is Used for treating heart failure. It was first introduced by Azurity Pharmaceuticals Inc in its drug Bidil on Jun 23, 2005. 3 different companies have introduced drugs containing Hydralazine Hydrochloride; Isosorbide Dinitrate.


Hydralazine Hydrochloride; Isosorbide Dinitrate Patents

Given below is the list of patents protecting Hydralazine Hydrochloride; Isosorbide Dinitrate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Bidil US6465463 Methods of treating and preventing congestive heart failure with hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate Sep 08, 2020

(Expired)

Azurity
Bidil US6784177 Methods using hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate Sep 08, 2020

(Expired)

Azurity



Hydralazine Hydrochloride; Isosorbide Dinitrate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Hydralazine Hydrochloride; Isosorbide Dinitrate Generic API Manufacturers

Several generic applications have been filed for Hydralazine Hydrochloride; Isosorbide Dinitrate. The first generic version for Hydralazine Hydrochloride; Isosorbide Dinitrate was by Riconpharma Llc and was approved on Apr 6, 2022. And the latest generic version is by I3 Pharmaceuticals Llc and was approved on Jan 17, 2024.

Given below is the list of companies who have filed for Hydralazine Hydrochloride; Isosorbide Dinitrate generic, along with the locations of their manufacturing plants worldwide.


1. I3 PHARMS

I3 Pharmaceuticals Llc has filed for 1 generic for Hydralazine Hydrochloride; Isosorbide Dinitrate. This 37.5mg;20mg version comes by the name ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by I3 Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
37.5MG; 20MG

tablet Prescription ORAL AB Jan 17, 2024





2. RICONPHARMA LLC

Riconpharma Llc has filed for 1 generic for Hydralazine Hydrochloride; Isosorbide Dinitrate. This 37.5mg;20mg version comes by the name ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Riconpharma Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
37.5MG; 20MG

tablet Prescription ORAL AB Apr 6, 2022


Manufacturing Plant Locations
New

Riconpharma Llc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Riconpharma Llc as present at those locations.

Country City Firm Name
United States
Denville RiconPharma LLC